Ascendis Pharma A/S

ASND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001612042

Price chart

Open-market purchases and sales by ASND insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 9, 20265:04 PM ETSep 8, 2026Bodenhoff MadsSVP & PAOSSaleOrdinary Shares−3K$270.19−$810.57K0−100.0%SEC
Sep 3, 20264:09 PM ETSep 2, 2026HOLTUG LARSDirectorSSaleOrdinary Shares−236$264.1296−$62.33K4K−5.6%SEC
Aug 18, 20269:02 PM ETAug 14, 2026BIENAIME JEAN JACQUESDirectorPPurchaseOrdinary Shares+2K$246.327+$492.65K2.9K+222.2%SEC
Jun 2, 2026Jun 2, 2026SMITH SCOTT THOMASEVP & Chief Financial OfficerPPurchaseOrdinary Shares+100$219.00+$21.9K4.37K+2.3%SEC
Jun 1, 2026May 29, 2026BIENAIME JEAN JACQUESDirectorPPurchaseOrdinary Shares+500$223.124+$111.56K900+125.0%SEC

The largest institutional positions in ASND at the end of Q2 2026.

Institutions holding ASND in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
RA CAPITAL MANAGEMENT, L.P.10,281,496$2.74B23.83%00.0%Unchanged
T. Rowe Price Investment Management, Inc.6,754,846$1.8B1.18%+592,804+9.6%Added
Avoro Capital Advisors LLC5,111,111$1.36B12.24%+48,611+1.0%Added
WESTFIELD CAPITAL MANAGEMENT CO LP4,798,267$1.28B4.18%−15,173−0.3%Reduced
Jupiter Topco LLC3,648,772$973.38M0.40%+3,648,772New